Test Price
2,800 AED✅ Home Collection Available
SNCA Gene (PARK1) Parkinson’s Disease Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين SNCA (PARK1) لمرض باركنسون بتقنية التسلسل الجيني NGS في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary / ملخص تنفيذي
- 99.9% Diagnostic Sensitivity – ISO 15189 & ISO 9001:2015 accredited NGS processing ensures clinical-grade accuracy.
- Premium Logistics – DHA-compliant, cold-chain home collection via certified phlebotomists (8 AM – 11 PM).
- Clinical Guidance – Telephonic post-test counselling with a DHA-licensed genetic neurologist included.
- Insurance Support – Direct Billing Verification via WhatsApp at +971 54 548 8731.
Overview / نظرة عامة
The SNCA Gene (PARK1) Parkinson’s Disease Genetic Test analyzes the alpha-synuclein gene using next-generation sequencing to detect pathogenic variants linked to autosomal dominant Parkinson’s disease. This UAE‑approved test supports early risk assessment, differential diagnosis, and informed family planning under strict genetic counselling protocols.
يحلل اختبار جين SNCA (PARK1) لمرض باركنسون باستخدام تقنية التسلسل الجيني من الجيل التالي الطفرات المرتبطة بالشكل الوراثي السائد للمرض، مما يدعم التقييم المبكر للمخاطر والتخطيط العائلي المستنير وفق بروتوكولات الاستشارة الوراثية المعتمدة.
| Feature | Our Test (NGS) ISO-Certified UAE Lab |
Closest Alternative Conventional Sanger / Panel |
|---|---|---|
| Technology | Next-Generation Sequencing (NGS) | Standard Sanger Sequencing |
| Variant Resolution | Single‑nucleotide, indel, CNV coverage | Targeted exons only (misses large rearrangements) |
| Reporting Standard | ACMG 2026 guidelines with clinical annotation | Binary mutation report without ACMG interpretation |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
Physician Insight & Safety Protocol
“A positive SNCA variant does not mean an absolute Parkinson’s diagnosis; clinical correlation with motor, autonomic and cognitive symptoms is essential. Genetic test results must be interpreted within the full neurological picture, and I strongly recommend post‑test genetic counselling for all family members.” – Dr. PRABHAKAR REDDY, DHA License: 61713011, Consultant Neurologist.
⚠️ Medication Safety Notice
Do not discontinue prescribed Parkinson’s medication or adjust dosage without consulting your treating physician. Abrupt withdrawal can lead to severe dyskinesia or neuroleptic malignant syndrome.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Individuals under 18 years without a UAE court order for genetic testing (CDS Law 2026).
- Exclusion: Inability to provide informed consent or absence of a legal guardian.
- Exclusion: Recent blood transfusion (<2 weeks) or active infection interfering with DNA integrity.
- Seek emergency care if you experience: sudden worsening of tremor, severe hallucinations, chest pain, or signs of neuroleptic malignant syndrome (high fever, rigidity, confusion).
Patient FAQ & Clinical Guidance
1. What does the SNCA gene Parkinson’s test actually detect?
Answer: This test identifies pathogenic mutations in the SNCA gene that cause or increase the risk of hereditary Parkinson’s disease.
الجواب: يكتشف هذا الاختبار الطفرات الممرضة في جين SNCA المسببة أو المعززة لخطر الإصابة بمرض باركنسون الوراثي.
2. Who should consider this genetic test in the UAE?
Answer: Individuals with a strong family history of early‑onset Parkinson’s or atypical tremor syndromes benefit most from this analysis.
الجواب: الأشخاص الذين لديهم تاريخ عائلي قوي بمرض باركنسون المبكر أو متلازمات الرعاش غير النمطية يستفيدون بشكل كبير من هذا التحليل.
3. How is the sample collected and how long until I receive my report?
Answer: A certified phlebotomist collects a small blood sample (or FTA card spot); results are finalized in 3 to 4 weeks.
الجواب: يقوم أخصائي سحب دم معتمد بجمع عينة دم صغيرة (أو بقعة على بطاقة FTA)، وتصدر النتائج خلال 3 إلى 4 أسابيع.
UAE Regulatory Compliance:
Federal Decree-Law No. 41 of 2024 on Genetic Testing (Art. 87) mandates certified genetic counselling prior to analysis. UAE CDS Law 2026 prohibits genetic testing on minors without judicial approval. All data processed under UAE PDPL standards.
ISO 9001:2015 Certified: Cert. INT/EGQ/2509DA/3139 | DHA Facility License: 9834453
Sample Requirements: Whole blood (EDTA), extracted DNA, or FTA card blood spot. Pre‑ genetic counselling and a detailed pedigree chart are required.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians